US sharemarkets turned positive late in the day. As in Europe, Donald Trump’s comments on drug pricing weighed on stock prices in the healthcare and biotechnology sectors.
Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X
Recent Posts
- Korean Insurers Eye India's $130 Billion MarketFebruary 7, 2026
- US to Make Payment to United NationsFebruary 7, 2026
- AI Trade Fractures as Costs MountFebruary 7, 2026
- France Urges Continued Reforms in LebanonFebruary 7, 2026
- Toyota Announces Surprise CEO SwitchFebruary 7, 2026
All Categories
- Battery Technology (2)
- Biotechnology (101)
- brekkie wrap (288)
- Broker News (2466)
- Commodities (1680)
- Hydrogen (6)
- Lithium (106)
- Potash (11)
- Rare Earths (6)
- Renewables (35)
- Company (7)
- Corporate Connect Research (24)
- Currencies (42)
- Cryptocurrencies (28)
- daily special (68)
- David Bassanese (90)
- Economics (3084)
- ESG (117)
- Etfs (500)
- EV Space (128)
- Featured (136)
- FinTech (26)
- Fixed Interest (231)
- FNN Content (6112)
- Franklin Templeton (1)
- fresh grind (2559)
- fundie guide (22)
- Funds (1422)
- Gavin Wendt (141)
- Greg Tolpigin (75)
- hot stocks (250)
- Infrastructure (28)
- Interest Rates (386)
- investor blend (65)
- IPOs (20)
- James Dunn (185)
- Kris Walesby (67)
- LICs (162)
- Marc Sinatra (4)
- market mocha (5341)
- Market Reports Text (283)
- Markets (14003)
- Media (71)
- Noosa Mining Conference (29)
- Podcasts (1)
- Politics (53)
- Product Profiles (23)
- Property (225)
- Reports (511)
- Retail (254)
- round table (8)
- Shane Oliver (260)
- Shares (18215)
- Stocks of the Hour (300)
- sip & learn (23)
- sip and learn (55)
- Sponsored Content (32)
- Strategy (204)
- Super (36)
- table for two (84)
- Technical Analysis (5)
- Technology (419)
- The Week that Was (112)
- Tim Boreham (85)
- Uncategorized (157)
- Video (4332)
- Webinars (195)
- Weekly Wrap (831)